ArticleBiometrics2026
Learning optimal early decision treatment rules with multi-domain intermediate outcomes.
Article in Biometrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Implementing precision medicine for mental disorders presents challenges due to disease complexity and heterogeneity in patient responses. Empirical studies suggest that early indicators, such as interim measures (e.g., interim patient self-reports) of disease improvement or relapse, can predict longer-term outcomes, serving as proxies when final outcomes (e.g., in-clinic assessments) are less accessible. However, existing approaches for deriving individualized treatment rules (ITRs) often ignore these early signals, instead focusing only on a final outcome as the reward. In this work, we propose a new method incorporating intermediate outcomes from various domains into a personalized composite outcome, serving as the reward for learning ITRs. This composite is a weighted sum of inferred latent states from observed measures, with weights personalized for each patient, ensuring consistency with the long-term final response. Our simulations show that this approach not only provides early detection of non-responders but also improves long-term treatment outcomes. Applying our framework to a randomized clinical trial on major depressive disorder (MDD) demonstrates its effectiveness and advantages in ITR learning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.